Search

Your search keyword '"Chan, Charles M."' showing total 47 results

Search Constraints

Start Over You searched for: Author "Chan, Charles M." Remove constraint Author: "Chan, Charles M."
47 results on '"Chan, Charles M."'

Search Results

6. Contributors

7. Use of Peripheral Nerve Blocks Is Not Associated With Decreased Postoperative Opioid Prescription After ACL Reconstruction in Adolescents.

8. Supplementary Figure S2 from Efficacy, Safety, and Pharmacokinetics of Axitinib in Nasopharyngeal Carcinoma: A Preclinical and Phase II Correlative Study

12. Clinical utility of plasma Epstein-Barr virus DNA and ERCC1 single nucleotide polymorphism in nasopharyngeal carcinoma

23. Lateral meniscus width at the popliteus recess and the relevance to saucerization of discoid lateral menisci

24. Radial Width of the Lateral Meniscus at the Popliteal Hiatus: Relevance to Saucerization of Discoid Lateral Menisci.

25. Colaboradores

26. Efficacy, Safety, and Pharmacokinetics of Axitinib in Nasopharyngeal Carcinoma: A Preclinical and Phase II Correlative Study

29. Clinical utility of plasma Epstein-Barr virus DNA andERCC1single nucleotide polymorphism in nasopharyngeal carcinoma

34. Proteomic Comparison of Nasopharyngeal Cancer Cell Lines C666-1 and NP69 Identifies Down-Regulation of Annexin II and β2-Tubulin for Nasopharyngeal Carcinoma

36. Prognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma—a prospective study

37. Proteomic Comparison of Nasopharyngeal Cancer Cell Lines C666-1 and NP69 Identifies Down-Regulation of Annexin II and β2-Tubulin for Nasopharyngeal Carcinoma.

38. Prognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma—a prospective study<FNR HREF="fn1"></FNR><FN ID="fn1">Part of this study was presented and discussed at the 13 May 2001 American Society of Clinical Oncology, San Francisco.</FN>

39. Single-nucleotide polymorphism (SNP) of excision repair cross complementation group 1 (ERCC1) in nasopharynx cancer (NPC): A companion biomarker study to Hong Kong NPC Study Group 0502 trial

40. Performance and Operational Feasibility of Epstein-Barr Virus-Based Screening for Detection of Nasopharyngeal Carcinoma: Direct Comparison of Two Alternative Approaches.

41. Opiate prescribing patterns in the adolescent population following anterior cruciate ligament reconstruction.

42. Sport Participation and Specialization Characteristics Among Pediatric Soccer Athletes.

43. Systematic evaluation of circulating inflammatory markers for hepatocellular carcinoma.

44. Proteomic comparison of nasopharyngeal cancer cell lines C666-1 and NP69 identifies down-regulation of annexin II and beta2-tubulin for nasopharyngeal carcinoma.

45. The effect of centrifugation on circulating mRNA quantitation opens up a new scenario in expression profiling from patients with metastatic colorectal cancer.

46. Cyclooxygenase-2 expression in advanced nasopharyngeal carcinoma--a prognostic evaluation and correlation with hypoxia inducible factor 1alpha and vascular endothelial growth factor.

47. Quantification and utility of monosialylated alpha-fetoprotein in the diagnosis of hepatocellular carcinoma with nondiagnostic serum total alpha-fetoprotein.

Catalog

Books, media, physical & digital resources